Large-scale testing (Phase 3)Study completedNCT05777174
What this trial is testing
Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring
Who this might be right for
Kidney DiseasesKidney InjuryKidney Failure
MediBeacon 149